ESCEO is a not-for-profit organization, dedicated to a close interaction between clinical scientists dealing with bone, joint and muscle disorder, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of Osteoporosis and Osteoarthritis within the comprehensive perspective of health resources use. The objective of ESCEO is to provide practitioners with the latest clinical and economic information.
exhibiting
with wisepress
Upcoming
26th International Society of Neurochemistry
20 - 24 Aug. 2017
World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Disorders (WCO-IOF-ESCEO)
2 - 5 April 2014,
Seville
Anticipated attendance: 4000 delegates
Delegate profile: Orthopedic specialists, GPs, nurses, researchers and scientiests
Conference code: IOF14A
Meeting website:www.wco-iof-esceo.org/WCO-IOF-ESCEO-SEVILLE%202014
Exhibition address:
FIBES, Palacio de Exposiciones y
Congresos
Avda. Alcalde Luis Uruñuela, 1
41020 Sevilla.
41020 Sevilla.
Spain
To download or print this page, click on the PDF icon
Exhibition overview
Exhibition details
Scientific ProgrammeTopics will include:
The Lifecourse Epidemiology of Musculoskeletal Ageing
Osteoporosis therapy, beyond fracture prevention
Fracture healing
New molecules against osteoarthritis
Hormone replacement therapy in male
Prevention of bone metastases
Development of anabolic medications in osteoporosis in Europe
Efficacy and safety of anti-osteoporosis medications in the elderly
Definition, pathophysiology and management of sarcopenia
Diabetes, obesity, metabolic syndrome and bone
Extraskeletal effects of Vitamin D
Risks/benefits of calcium and/or Vitamin D
Bariatric surgery and bone
Inadequate response in osteoporosis therapy
Prevention of GIOP
Management of Osteoporosis in Patients with Rheumatoid Arthritis
Health economics in osteoarthritis
Which patients should be treated in osteoarthritis?
PTH and bone, lessons from hypoparathyroidism therapy
How long can bone turnover be suppressed?
Management of osteoporosis in Latin America
Management of osteoporosis in Middle East
Responders in osteoarthritis treatment
New imaging modalities in osteoporosis
Side-effects of corticosteroids in rheumatoid arthritis
Deadline details
- Entry into Wisepress Congress Price List: Feb. 25, 2014
- Receipt of display material: March 4, 2014
Exhibition shipping address for late entries
Publishers who miss the display materials deadline date need to send their material directly to the exhibition:
Please contact Wisepress for full shipping details.
Wisepress will be mounting a full display of books and journals at this meeting.
To ensure your publications are included please contact us at:
marketing@wisepress.com
Please click here for our terms and conditions.